Organization | Moi Univeristy

Moi Univeristy Report issue

Academic/Hospital Phase 3 Phase 4

Founded: Kesses Kenya (1984)

Organization Overview

First Clinical Trial

2006

NCT00562874

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Moi Univeristy | Moi University

Active Ingredients

Drugs in Phase 4 Trials (1)

vincristine (oncovin) (1 trial)

Drugs in Phase 3 Trials (2)

azithromycin (zithromax) (1 trial)

Drugs in Other Trials (4)

artemisinin (2 trials)

human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (1 trial)

oxygen (1 trial)

soybean (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Death (Phase 3)

Infections (Phase 3)

Maternal Death (Phase 3)

Neonatal Sepsis (Phase 3)

Perinatal Death (Phase 3)

Pregnancy Complications, Infectious (Phase 3)

Puerperal Infection (Phase 3)

Sepsis (Phase 3)

Toxemia (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 8
# of Trial APIs: 7